Evidence map›Paper›PMID 27586333›Full record

ArticleMethods in enzymology2016

Engineering and Application of LOV2-Based Photoswitches.

S P Zimmerman, B Kuhlman, H Yumerefendi

Abstract read
In one paragraph

Article in Methods in enzymology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Allosteric regulation of kinase activity in living cells.bioRxiv : the preprint server for biology · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Engineering Optogenetic Protein Analogs.Methods in molecular biology (Clifton, N.J.) · 2020
    Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

S P ZimmermanUniversity of North Carolina Chapel Hill, Chapel Hill, NC, United States.
B KuhlmanUniversity of North Carolina Chapel Hill, Chapel Hill, NC, United States. Electronic address: bkuhlman@email.unc.edu.
H YumerefendiUniversity of North Carolina Chapel Hill, Chapel Hill, NC, United States. Electronic address: yumer@unc.edu.

Funding

Spatiotemporal Control of the Epigenome via Photoactivatable Nuclear LocalizationR01DA036877 · NIDA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI HAHN, KLAUS M., KUHLMAN, BRIAN A · 2013 to 2017
$2.1M
NIDA NIH HHS R01 DA036877
6 · The paper itself

Abstract

Cellular optogenetic switches, a novel class of biological tools, have improved our understanding of biological phenomena that were previously intractable. While the design and engineering of these proteins has historically varied, they are all based on borrowed elements from plant and bacterial photoreceptors. In general terms, each of the optogenetic switches designed to date exploits the endogenous light-induced change in photoreceptor conformation while repurposing its effect to target a different biological phenomenon. We focus on the well-characterized light-oxygen-voltage 2 (LOV2) domain from Avena sativa phototropin 1 as our cornerstone for design. While the function of the LOV2 domain in the context of the phototropin protein is not fully elucidated, its thorough biophysical characterization as an isolated domain has created a strong foundation for engineering of photoswitches. In this chapter, we examine the biophysical characteristics of the LOV2 domain that may be exploited to produce an optogenetic switch and summarize previous design efforts to provide guidelines for an effective design. Furthermore, we provide protocols for assays including fluorescence polarization, phage display, and microscopy that are optimized for validating, improving, and using newly designed photoswitches.

Indexed as

LightAvenaFlavoproteinsModels, MolecularPhototropinsProtein EngineeringProtein Structure, TertiaryFlavoproteinsPhototropinsBlue lightLOV2OptogeneticsPeptide cagingPhage displayPhotoswitchesProtein designProtein engineering

Identifiers

PMID27586333
PMCPMC5369018

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.